# Treatment of Covid-19 With a Herbal Compound, Xagrotin

> **NCT05017493** · PHASE1,PHASE2 · COMPLETED · sponsor: **Biomad AS** · enrollment: 661 (actual)

## Conditions studied

- Covid19

## Interventions

- **COMBINATION_PRODUCT:** Xagrotin

## Key facts

- **NCT ID:** NCT05017493
- **Lead sponsor:** Biomad AS
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-01
- **Primary completion:** 2020-12-07
- **Final completion:** 2021-02-08
- **Target enrollment:** 661 (ACTUAL)
- **Last updated:** 2021-12-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05017493

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05017493, "Treatment of Covid-19 With a Herbal Compound, Xagrotin". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05017493. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*